Wenzhi Tian, based in Shanghai, Shanghai, China, is currently a Chairman, Founder, and Chief Executive Officer at Immuneonco Biopharma, bringing experience from previous roles at Huabo Biopharma, Imclone Systems, a Wholly-Owned Subsidiary of Eli Lilly and Company and Weill Cornell Medicine. Wenzhi Tian holds a 1997 - 2001 North Shure University Hospital. Wenzhi Tian has 2 emails on RocketReach.